Karnataka State AIDS Prevention Society, Bangalore, India.
J Int AIDS Soc. 2013 Aug 27;16(1):18502. doi: 10.7448/IAS.16.1.18502.
One important operational challenge facing antiretroviral treatment (ART) programmes in low- and middle-income countries is the loss to follow-up between diagnosis of human immunodeficiency virus (HIV) and initiation of ART. This is a major obstacle to achieving universal access to ART. This study from Karnataka, India, tried to measure such losses by determining the number of HIV-positive individuals diagnosed, the number of them reaching ART centres, the number initiated on ART and the reasons for non-initiation of ART.
A review of records routinely maintained under the National AIDS Control Programme (NACP) was carried out in six districts of Karnataka. HIV-positive persons diagnosed during the months from January to June 2011 in 233 public HIV-testing sites were followed up until December 2011 based on the pre-ART registers. A chi-square test was used to assess statistical significance.
Of 2291 HIV-positive persons diagnosed (52% male; mean age of 35 years), 1829 (80%) reached ART centres. Of the latter, 1166 (64%) were eligible for ART, and 959 (82%) were initiated on treatment. Overall losses (attrition) on the road between HIV diagnosis and ART initiation were 669 (29%). Deaths, migration and not willing to go to the ART centres were cited as the main known reasons for not reaching ART centres. For ART-eligible individuals who did not initiate ART, the most common known reasons for non-initiation included dying before initiation of ART and not being willing to start ART.
In a large state of India, eight in ten HIV-positive persons reached ART centres, and of those found ART eligible, 82% start treatment. Although this is an encouraging achievement, the programme needs to take further steps to improve the current performance by further reducing pre-ART attrition. We recommend online registering of diagnosed HIV-positive patients to track the patients more efficiently.
在中低收入国家,艾滋病抗病毒治疗(ART)项目面临的一个重要运营挑战是在艾滋病毒(HIV)诊断和开始 ART 之间失去后续治疗。这是实现普及 ART 的主要障碍。这项来自印度卡纳塔克邦的研究试图通过确定诊断出的 HIV 阳性人数、到达 ART 中心的人数、开始接受 ART 的人数以及未开始 ART 的原因来衡量这种损失。
在卡纳塔克邦的六个地区,对国家艾滋病控制计划(NACP)常规保存的记录进行了审查。根据 pre-ART 登记册,对 2011 年 1 月至 6 月期间在 233 个公共 HIV 检测点诊断出的 HIV 阳性者进行了随访,直至 2011 年 12 月。使用卡方检验评估统计显著性。
在 2291 名诊断为 HIV 阳性的患者中(52%为男性;平均年龄为 35 岁),有 1829 人(80%)到达 ART 中心。在后者中,有 1166 人(64%)符合 ART 条件,有 959 人(82%)开始接受治疗。HIV 诊断与 ART 开始之间的道路上总体损失(流失)为 669 人(29%)。死亡、迁移和不愿前往 ART 中心被认为是未到达 ART 中心的主要已知原因。对于不符合 ART 条件但未开始 ART 的合格个体,未开始 ART 的最常见已知原因包括在开始 ART 之前死亡和不愿开始 ART。
在印度的一个大邦,十分之八的 HIV 阳性者到达了 ART 中心,在符合 ART 条件的人群中,有 82%开始接受治疗。尽管这是一项令人鼓舞的成就,但该计划需要采取进一步措施,通过进一步减少 pre-ART 流失来提高当前的表现。我们建议对诊断出的 HIV 阳性患者进行在线登记,以更有效地跟踪患者。